SavedAdd your journal

Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2013 / Cilt: 22 - Sayı: 1

Lactic acidosis secondary to metformin in a patient presenting with acute renal failure due to diarrhea: Case report

Metformin kullanırken diyare ve akut böbrek yetmezliği gelişen hastada, metformine bağlı laktik asidoz: Olgu sunumu

Meltem DEMİRCİ SEZİŞ
Mehmet ÖZKAHYA
Mustafa YAPRAK
Mehmet Nuri TURAN
Aygül ÇELTİK
Erhan TATAR
Arzu Nazlı ZEKA
Hüsnü PULLUKÇU
Pages
133–135
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Metformin may cause lactic acidosis among patients with acute renal failure; early hemodialysis provides rapid clinical improvement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metformin is a biguanide used in the treatment of type 2 diabetic patients with normal renal functionLactic acidosis is the most serious side effect of metformin.
📊
Key Findings & Data:A 68-year-old female patient used metformin was admitted to the infectious disease department due to diarrhea, nausea and vomiting.
💡
Conclusion & Impact:Metformin may cause lactic acidosis among patients with acute renal failure; early hemodialysis provides rapid clinical improvement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Metformin is a biguanide used in the treatment of type 2 diabetic patients with normal renal functionLactic acidosis is the most serious side effect of metformin. Renal failure is the most common cause of reduced lactate excretion. It is aimed to present a case of metformin-induced lactic acidosis exacerbated by acute renal failure. A 68-year-old female patient used metformin was admitted to the infectious disease department due to diarrhea, nausea and vomiting. Type B lactic acidosis due to metformin was diagnosed after the detection of high anion gap metabolic acidosis and high lactate level on blood gas analysis. Hemodialysis was performed because of acute renal failure. The patient was discharged on the 11th day of the hospitalization with normal serum parameters. Metformin may cause lactic acidosis among patients with acute renal failure; early hemodialysis provides rapid clinical improvement.

Özet

Metformin biguanid sınıfından, Tip 2 diyabetiklerde, özellikle böbrek fonksiyonları normal hastalarda ilk basamakta kullanılan oral antidiyabetiktir. Metforminin en ciddi yan etkisi laktik asidozdur. Böbrek yetersizliği laktat atılım bozukluğunun en sık sebebidir. Metformin kullanan bir hastada gelişen akut böbrek yetersizliğinin alevlendirdiği laktik asidoz tablosunun sunulması amaçlanmıştır. Atmış sekiz yaşında bayan hasta metformin kullanırken iki haftadır devam eden ishal, bulantı ve kusma yakınmaları ile enfeksiyon hastalıkları servisine yatırıldı. Kan gazında artmış anyon açıklı metabolik asidoz saptandı. Laktik asit düzeyi yüksek saptanması üzerine metformin kullanımına bağlı Tip B laktik asidoz olarak değerlendirildi. Hasta akut böbrek yetmezliği nedeni ile hemodiyalize alındı. Yatışının 11. gününde tüm kan parametreleri düzelmiş olarak şifa ile taburcu edildi. Metformin böbrek yetersizliği gelişen hastalarda laktik asidoza sebep olabilmektedir, bu hastalarda erken diyaliz klinik durumun hızla düzelmesini sağlar.

🔖

Cite This Article

SEZİŞ, M. D., ÖZKAHYA, M., YAPRAK, M., TURAN, M. N., ÇELTİK, A., TATAR, E., ZEKA, A. N., PULLUKÇU, H. (2022). Lactic acidosis secondary to metformin in a patient presenting with acute renal failure due to diarrhea: Case report. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 22 - Sayı: 1, 133–135. https://ajindex.com/articles/636323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. American Diabetes Association: Standards of medical care in diabetes-2009. Diabetes Care 2009; 32 Suppl 1: S13-61 Kirpichnikov D, McFarlane SI, Sowers JR: Metformin: An update. Ann Intern Med 2002; 137: 25–33 Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi S, Schumann W, Petersen K, Landau B, Shulman G: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000; 49: 2063–2069
  2. Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ: Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab 2006; 291: E182–E189 Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL: Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147: 386–399 Khurana R, Malik IS: Metformin: Safety in cardiac patients. Heart 2010; 96: 99-102
  3. Stang M, Wysowski D K, Butler-Jones: Incidence of lactic acidosis in metformin users. Diabetes Care 1999; 22: 925–927 Maharani U: Diabetes Mellitus & Hypoglycemia (49th ed). In: Papadakis MA, McPhee SJ (eds), Current Medical Diagnosis and Treatment 2010. McGraw-Hill Medical, 2009; 1092-1093
  4. Shu AD, Myers Jr MG, Shoelson SE: Chapter 29: Pharmacology of the Endocrine Pancreas. In: Golan ED (ed), PrinciplesPharmacology: The Pathophysiologic Basis of Drug Therapy. Philadelphia: Lippincott, Williams & Wilkins, 2005;540-541
  5. El-Hennawy AS, Jacob S, Mahmood AK: Metformin-associated lactic acidosis precipitated by diarrhea. Am J Ther 2007; 14: 403-405
  6. Pertek JP, Vidal S, Mariot J, Galy-Floc’h M, Azoulay E: Metformin- associated lactic acidosis precipitated by acute renal failure. AnnAnesth Reanim 2003; 22:457-460
  7. Di Grande A, Vancheri F, Giustolisi V, Giuffrida C, NarboneLicata M, Le Moli C, Riccobene S, Burgio A, Bartolotta S, NigroCannone V: Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure. Clin Ter 2008; 159: 87-89
  8. Teale KF, Devine A, Stewart H, Harper NJ: The managementmetformin overdose. Anaesthesia 1998; 53: 698-701
  9. Schelling JR, Howard RL, Winter SD, Linas SL: Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis. Ann Intern Med 1990; 113: 580-582
  10. Hermann LS, Melander A: Biguanides: basic aspects and clinical uses. In: Alberti KGMM, Zimmet P, DeFronzo RA (eds): International Textbook of Diabetes Mellit